A positive patient experience is the ultimate goal in healthcare, and leading pharma and biotech companies are increasingly focusing on patient-centricity as a core aspect of brand strategy.
By viewing the patient as a whole—considering their physical, emotional, and socio-economic needs—biopharma firms can create more effective treatments and build stronger brand loyalty. In doing so, they help to address patient needs more effectively while contributing to long-term brand success in competitive marketplaces.
So, how do biopharma leaders put the patient lens at the center of their brand strategies?
At a recent webinar, Dawn Payne, Novartis Associate Director, Business Insights & Marketing Research (Malignant Hematology), teamed up with Branding Science’s Kathy Relias, Head of Commercial Strategic Development and Client Service, US, and David Spears, President, for a thought-provoking discussion about placing patients at the heart of innovation.
Click here to read the full article and dive into their key insights, or for a more in-depth look, click here to watch the webinar on demand.
Get in touch:
David Spears, President, Branding Science: [email protected]